Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
from NDTV News - Topstories https://ift.tt/3uGvRch
MASIGNASUKAv102
6510051498749449419
comment 0 Comments
more_vert